The report provides a detailed analysis essential for establishing a Zolpidem production plant. It encompasses all critical aspects necessary for Zolpidem production, including the cost of Zolpidem production, Zolpidem plant cost, Zolpidem production costs, and the overall Zolpidem production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Zolpidem production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Zolpidem, commonly known as Ambien, is an FDA-approved drug primarily used for short-term treatment of insomnia, particularly in patients having trouble in sleep. It is a non-benzodiazepine hypnotic drug that significantly enhances GABA (gamma-aminobutyric acid) inhibitory activity by binding to the GABA-A receptors in the brain, leading to sedation. It is a short-acting hypnotic drug that improves sleep quality in patients with long-term insomnia and has muscle relaxant properties. It also contributes to decreasing the sleep latency and increasing the duration of sleep, especially in patients with temporary insomnia. Clinicians also utilize it for anxiety and stress.
Several factors influence the procurement demand for Zolpidem. The most prominent factor is the increasing prevalence of insomnia and sleeping disorders. The global surge in cases of sleeping disorders and the growing awareness among patients contribute to its increasing market demand. The availability of various formulations of Zolpidem, such as sublingual tablets and oral sprays, enhances patient compliance, leading to its increased demand and significance. Moreover, the aging population is more susceptible to sleeping disorders, thereby increasing its utilization in their treatment regimen.
The availability of Zolpidem in generic forms increases its affordability, making it a favorable intervention for patients, thereby boosting its market growth. Overall, the industrial Zolpidem procurement is influenced by its therapeutic efficacy in the pharmaceutical and medical industries as a short-acting hypnotic-sedative drug to alleviate insomnia, the increasing incidence of insomnia and sleeping disorders, growing awareness in patients towards healthy sleep cycle, the aging population, technological advancements, cost-effectiveness, and regulatory approvals.
Raw Material for Zolpidem Production
According to the Zolpidem production plant project report, the key raw materials used in the production of Zolpidem include 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine.
Production Process of Zolpidem
The extensive Zolpidem production cost report consists of the following major industrial production processes:
- Production from Mannich aminomethylation: The production process of Zolpidem by Mannich aminomethylation involves several key steps. In the first step, 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine is reacted with formalin and dimethylamine in the presence of acetic acid to form an intermediate. This intermediate is treated with methyliodide to form a quaternary ammonium salt. Further, the salt undergoes cyanation using sodium cyanide to obtain another intermediate. In the next step, hydrolysis of this intermediate with alcoholic KOH forms Zolpidic acid. Finally, Zolpidic acid is subjected to amidation carbonyldiimidazole and anhydrous dimethylamine to yield Zolpidem.
- Production from formylation process: This process starts with the treatment of 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine with oxalylchloride and dimethylformamide to form an intermediate, which on further reduction with sodium borohydride forms an alcohol derivative. This compound is treated with p-toluenesulfonylchloride in pyridine to obtain a salt, which is reacted with sodium cyanide to form another intermediate. This intermediate is subjected to further amidation by using carbonyldiimidazole (CDI) and gaseous dimethylamine to yield Zolpidem.
Zolpidem, commonly known as Ambien, is a white to off-white crystalline powder, having the molecular formula C19H21N3O and a molecular weight of 307.4 g/mol. It has a melting point of 196 °C and solubility of 23 mg/ml °C. It is slightly soluble in water and sparingly soluble in methanol. It has a pKa value of 5.65. Zolpidem is a short-acting hypnotic-sedative, used in the treatment of long-term insomnia and various sleep disorders.
